Position in SYK
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$939,797
-$422,865 QoQ
Shares Held
2,985
-28.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,222
of 2,258 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SYK Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026TRANSCEND CAPITAL ADVISORS, LLC holds $6,739,451 across 9 Medical Devices names. SYK ranks #3 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
25,532 | $1,997,368 | |
| 2 | NVCR |
NovoCure Ltd
|
117,221 | $1,775,898 | |
| 3 | SYK |
Stryker Corp
This page
|
2,985 | $939,797 | |
| 4 | ABT |
Abbott Laboratories
|
5,910 | $536,273 | |
| 5 | BIO |
Bio-Rad Laboratories, Inc.
|
1,519 | $445,993 | |
| 6 | STE |
STERIS plc
|
1,406 | $296,061 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
4,478 | $286,636 | |
| 8 | BSX |
Boston Scientific Corp
|
5,476 | $233,715 |
All Filings in SYK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $939,797 | 2,985 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,362,662 | 4,147 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,430,766 | 6,916 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $3,724,055 | 10,074 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $4,215,833 | 10,656 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $4,226,154 | 11,353 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $3,939,667 | 10,942 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $3,543,960 | 9,810 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $3,274,906 | 9,625 | Shares | Sole | 2024-07-02 | |
| 2024-03-31 | $2,913,061 | 8,140 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2,148,326 | 7,174 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,851,130 | 6,774 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $1,929,389 | 6,324 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $1,482,731 | 5,194 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $747,161 | 3,056 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $574,808 | 2,838 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $580,875 | 2,920 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $773,176 | 2,892 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $697,163 | 2,607 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $620,269 | 2,352 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $610,884 | 2,352 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $572,900 | 2,352 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $576,334 | 2,352 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $415,698 | 1,995 | Shares | Defined | 2020-11-13 | |
| 2020-03-31 | $341,304 | 2,050 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||